Skip to Content

R529 (Divalproex Sodium Delayed-Release 125 mg)

Pill with imprint R529 is Brown, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 125 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for R529

Divalproex sodium delayed-release 125 mg R529

Divalproex Sodium Delayed-Release

Imprint
R529
Strength
125 mg
Color
Brown
Size
12.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC)
55111-0529
Inactive Ingredients
acetone, hypromellose, hypromellose phthalate (31% phthalate, 40 cst), isopropyl alcohol, methylene chloride, microcrystalline cellulose, povidone, corn starch, silicon dioxide, magnesium silicate, titanium dioxide, vanillin, shellac, ferrosoferric oxide, butyl alcohol, soya lecithin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "R529"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.